Free Defeat Cancer by Connie Strasheim Page B

home, including our five-day liver and intestinal cleanses, and juice fasts. We have patients who come to us from all over the world, and we teach them how to do everything here so that they can do our protocols at home.
Considerations in Treatment
    Before we take on new patients, we determine whether or not we will be able to help them. If they contact us from Memorial Sloan-Kettering, half-conscious and with a breathing tube, we know that they aren’t going to be able to do our program, because they have to be able to swallow the pills that we give them. Patients also have to have the motivation to want to do it. Just because their cousin or grandmother wants them to do it, isn’t good enough. They have to be interested in it. So we select patients who can physically do the program and who want to do it. I also do the program myself for general prevention against cancer. I have taken a lot of pills for 29 years, but it’s no big deal to me. It’s a question of mindset. If people think that taking pills and drinking carrot juice is going to be a nightmare, then it will be. Most of my patients are enthusiastic, appreciate the program, and want to be here, so they just dive in and do it. Usually compliance to the regimen and ability to do it are a non-issue.
    Many of my patients had health problems before getting cancer, including typical epidemic degenerative diseases like heart disease, diabetes, allergies and high cholesterol; basically, all kinds of problems. So when they come to my office for treatment, we give them the full package. We treat all of their problems, not just their cancers. Often, when we give them the nutrients that they need, their other health problems resolve. And people do come to us fortreatment for other diseases besides cancer or along with cancer. We just accept it and do what we have to do. People are afflicted with a lot of health problems. That’s just the reality of life today.
Treatment Outcomes
    If you look at my website, you will see that, overall, most of our patients do well. However, this includes only those who comply fully with the program. The success rate for pancreatic cancer is lower because it’s a very aggressive disease, but many do well over the long term, as evidenced by the case reports on my website. Usually those that don’t do well have a really advanced stage of cancer.
    So what do I mean when I say that my patients “do well?” The current drug that is used to treat pancreatic cancer, and which was given FDA approval, extends the patient’s life by a month, on average, and this is definitely not what I mean by “doing well!” If I only extended my patients’ lives by one month; if that was the best that I could do for them, I would quit my job. I would go sell shoes, literally! What I mean by “doing well” can be defined by the testimonials that are on my website. For example, I had a patient who was diagnosed in September 1991 with metastatic pancreatic cancer that had spread to his adrenals, lungs, and bones. He also had four tumors in his liver, and he was seventy years old at the time. The man lasted until he was seriously injured in an automobile accident and died in a rehab center. He didn’t die of cancer. All of his tumors disappeared and he lived for fifteen years beyond his diagnosis. His case is how I define “doing well,” and represents the average improvement and survival rate that we see and expect at our office.
    I receive oncology journals here at my office. Recently, I read about a supposedly miraculous new immune therapy for melanoma. The results of its use show that, on average, it extends the patient’s life by one or two months, which increases the two-year survival rate statistics for metastatic melanoma from 10-12 to 20 percent. It’s an improvement, but it’s not the same as having most of your patientsstill alive after a minimum of five years—which are the typical results that we get at my office. But the medical community